PANAGORA ASSET MANAGEMENT INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$247,264
-34.3%
57,237
+0.2%
0.00%0.0%
Q2 2023$376,296
-69.9%
57,101
-69.0%
0.00%
-75.0%
Q1 2023$1,250,345
-42.3%
184,145
-37.2%
0.01%
-42.9%
Q4 2022$2,168,544
+12.1%
293,443
+49.9%
0.01%
+7.7%
Q3 2022$1,934,000
+50.5%
195,760
+66.1%
0.01%
+62.5%
Q2 2022$1,285,000
+144.3%
117,880
+153.3%
0.01%
+166.7%
Q1 2022$526,000
-9.2%
46,531
+26.1%
0.00%0.0%
Q4 2021$579,000
-8.4%
36,8890.0%0.00%0.0%
Q3 2021$632,000
-20.3%
36,8890.0%0.00%
-25.0%
Q2 2021$793,000
+1834.1%
36,889
+1237.0%
0.00%
Q1 2021$41,000
-95.6%
2,759
-96.1%
0.00%
-100.0%
Q4 2020$930,000
+36.2%
70,765
+0.0%
0.01%
+50.0%
Q3 2020$683,000
-12.2%
70,732
+4.0%
0.00%
-20.0%
Q2 2020$778,000
-53.0%
68,006
-57.4%
0.01%
-58.3%
Q1 2020$1,654,000
-82.1%
159,670
-71.7%
0.01%
-71.4%
Q4 2019$9,252,000
+57.9%
563,795
+27.8%
0.04%
+55.6%
Q3 2019$5,859,000
-11.5%
441,179
-6.2%
0.03%
-10.0%
Q2 2019$6,624,000
-13.8%
470,122
+12.5%
0.03%
-11.8%
Q1 2019$7,686,000
-29.9%
417,730
-0.4%
0.03%
-33.3%
Q4 2018$10,960,000
+11.0%
419,459
-2.5%
0.05%
+37.8%
Q3 2018$9,871,000
+58.9%
430,093
+31.9%
0.04%
+48.0%
Q2 2018$6,213,000
+33.1%
326,138
+17.7%
0.02%
+38.9%
Q1 2018$4,668,000
+14.4%
277,016
+3.2%
0.02%
+20.0%
Q4 2017$4,082,000
-0.7%
268,534
+16.9%
0.02%
-6.2%
Q3 2017$4,111,000
+170.8%
229,677
+146.7%
0.02%
+166.7%
Q2 2017$1,518,000
+1.2%
93,110
-13.1%
0.01%0.0%
Q1 2017$1,500,000
+33.9%
107,124
+52.5%
0.01%
+20.0%
Q4 2016$1,120,000
+89.5%
70,230
+97.8%
0.01%
+66.7%
Q3 2016$591,000
+688.0%
35,512
+294.3%
0.00%
Q1 2016$75,000
+56.2%
9,007
+74.7%
0.00%
Q4 2015$48,000
+20.0%
5,157
+44.7%
0.00%
Q3 2015$40,000
-80.3%
3,565
-77.7%
0.00%
-100.0%
Q2 2015$203,000
+3.6%
16,010
-24.1%
0.00%0.0%
Q1 2015$196,000
+317.0%
21,084
+636.2%
0.00%
Q1 2014$47,0002,8640.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders